BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30974211)

  • 1. Hermansky-Pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literature.
    Dell'Acqua F; Saettini F; Castelli I; Badolato R; Notarangelo LD; Rizzari C
    J Allergy Clin Immunol Pract; 2019; 7(7):2476-2478.e5. PubMed ID: 30974211
    [No Abstract]   [Full Text] [Related]  

  • 2. Lethal hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type II.
    Enders A; Zieger B; Schwarz K; Yoshimi A; Speckmann C; Knoepfle EM; Kontny U; Müller C; Nurden A; Rohr J; Henschen M; Pannicke U; Niemeyer C; Nurden P; Ehl S
    Blood; 2006 Jul; 108(1):81-7. PubMed ID: 16551969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial albinism and immunodeficiency in patients with Hermansky-Pudlak Type II: Introducing 2 novel mutations.
    Alizadeh Z; Nabilou S; Mazinani M; Tajik S; Hamidieh AA; Houshmand M; Fazlollahi MR; Pourpak Z
    Scand J Immunol; 2021 Jan; 93(1):e12966. PubMed ID: 32869296
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel AP3B1 mutations in a Hermansky-Pudlak syndrome type2 with neonatal interstitial lung disease.
    Matsuyuki K; Ide M; Houjou K; Shima S; Tanaka S; Watanabe Y; Tomino H; Egashira T; Takayanagi T; Tashiro K; Okamura K; Suzuki T; Miyamoto T; Shibata H; Yasumi T; Nishikomori R
    Pediatr Allergy Immunol; 2022 Feb; 33(2):e13748. PubMed ID: 35212049
    [No Abstract]   [Full Text] [Related]  

  • 5. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2.
    Jessen B; Bode SF; Ammann S; Chakravorty S; Davies G; Diestelhorst J; Frei-Jones M; Gahl WA; Gochuico BR; Griese M; Griffiths G; Janka G; Klein C; Kögl T; Kurnik K; Lehmberg K; Maul-Pavicic A; Mumford AD; Pace D; Parvaneh N; Rezaei N; de Saint Basile G; Schmitt-Graeff A; Schwarz K; Karasu GT; Zieger B; Zur Stadt U; Aichele P; Ehl S
    Blood; 2013 Apr; 121(15):2943-51. PubMed ID: 23403622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel AP3B1 compound heterozygous mutations in a Japanese patient with Hermansky-Pudlak syndrome type 2.
    Nishikawa T; Okamura K; Moriyama M; Watanabe K; Ibusuki A; Sameshima S; Masamoto I; Yamazaki I; Tanita K; Kanekura T; Kanegane H; Suzuki T; Kawano Y
    J Dermatol; 2020 Feb; 47(2):185-189. PubMed ID: 31820501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutation causing Hermansky-Pudlak Syndrome Type 2.
    Chiang PW; Spector E; Thomas M; Frei-Jones M
    Pediatr Blood Cancer; 2010 Dec; 55(7):1438. PubMed ID: 20981699
    [No Abstract]   [Full Text] [Related]  

  • 8. Biallelic mutations in AP3D1 cause Hermansky-Pudlak syndrome type 10 associated with immunodeficiency and seizure disorder.
    Mohammed M; Al-Hashmi N; Al-Rashdi S; Al-Sukaiti N; Al-Adawi K; Al-Riyami M; Al-Maawali A
    Eur J Med Genet; 2019 Nov; 62(11):103583. PubMed ID: 30472485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Familial pulmonary fibrosis in 2 Mexican sisters with Hermansky-Pudlak syndrome].
    Zamora AC; Alonso-Martínez D; Barrera L; Mendoza F; Gaxiola M; Carrillo G
    Arch Bronconeumol; 2009 Aug; 45(8):408-10. PubMed ID: 19410348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGS-based 100-gene panel of hypopigmentation identifies mutations in Chinese Hermansky-Pudlak syndrome patients.
    Wei A; Yuan Y; Bai D; Ma J; Hao Z; Zhang Y; Yu J; Zhou Z; Yang L; Yang X; Li L; Li W
    Pigment Cell Melanoma Res; 2016 Nov; 29(6):702-706. PubMed ID: 27593200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel nonsense mutation in a patient with Hermansky-Pudlak syndrome type 4.
    Sandrock-Lang K; Böckelmann D; Eberl W; Schmitt-Kästner S; Zieger B
    Blood Cells Mol Dis; 2018 Mar; 69():113-116. PubMed ID: 29108692
    [No Abstract]   [Full Text] [Related]  

  • 12. Hermansky-Pudlak syndrome type 2: Aberrant pre-mRNA splicing and mislocalization of granule proteins in neutrophils.
    de Boer M; van Leeuwen K; Geissler J; van Alphen F; de Vries E; van der Kuip M; Terheggen SWJ; Janssen H; van den Berg TK; Meijer AB; Roos D; Kuijpers TW
    Hum Mutat; 2017 Oct; 38(10):1402-1411. PubMed ID: 28585318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease.
    Gochuico BR; Huizing M; Golas GA; Scher CD; Tsokos M; Denver SD; Frei-Jones MJ; Gahl WA
    Mol Med; 2012 Feb; 18(1):56-64. PubMed ID: 22009278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare cause of interstitial lung disease: Hermansky-Pudlak syndrome.
    Ciledağ A; Cirit Koçer B; Köktürk N; Kaya A; Celik G; Numanoğlu N
    Tuberk Toraks; 2011; 59(1):85-8. PubMed ID: 21554237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1.
    Wenham M; Grieve S; Cummins M; Jones ML; Booth S; Kilner R; Ancliff PJ; Griffiths GM; Mumford AD
    Haematologica; 2010 Feb; 95(2):333-7. PubMed ID: 19679886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a homozygous deletion in the AP3B1 gene causing Hermansky-Pudlak syndrome, type 2.
    Jung J; Bohn G; Allroth A; Boztug K; Brandes G; Sandrock I; Schäffer AA; Rathinam C; Köllner I; Beger C; Schilke R; Welte K; Grimbacher B; Klein C
    Blood; 2006 Jul; 108(1):362-9. PubMed ID: 16537806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile-onset inflammatory bowel disease in a patient with Hermansky-Pudlak syndrome: a case report.
    Ishihara J; Mizuochi T; Uchida T; Takaki Y; Konishi KI; Joo M; Takahashi Y; Yoshioka S; Kusano H; Sasahara Y; Yamashita Y
    BMC Gastroenterol; 2019 Jan; 19(1):9. PubMed ID: 30634918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular pathologic features of Hermansky-Pudlak syndrome type 1 in an adult.
    Zhou M; Gradstein L; Gonzales JA; Tsilou ET; Gahl WA; Chan CC
    Arch Ophthalmol; 2006 Jul; 124(7):1048-51. PubMed ID: 16832032
    [No Abstract]   [Full Text] [Related]  

  • 19. Hermansky-Pudlak syndrome: Report of two patients with updated genetic classification and management recommendations.
    Loredana Asztalos M; Schafernak KT; Gray J; Berry A; Paller AS; Mancini AJ
    Pediatr Dermatol; 2017 Nov; 34(6):638-646. PubMed ID: 29044644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome.
    Ammann S; Schulz A; Krägeloh-Mann I; Dieckmann NM; Niethammer K; Fuchs S; Eckl KM; Plank R; Werner R; Altmüller J; Thiele H; Nürnberg P; Bank J; Strauss A; von Bernuth H; Zur Stadt U; Grieve S; Griffiths GM; Lehmberg K; Hennies HC; Ehl S
    Blood; 2016 Feb; 127(8):997-1006. PubMed ID: 26744459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.